Also identified were epidermal growth factor receptor (EGFR) which is overexpressed in many cancers and stimulates a number of oncogenic signaling pathways, endomucin (EMCN), a matrix glycoprotein that interferes with cancer cell cellular adhesion, and fractalkine (CX3CL1), both of which promote cancer cell migration. The gene discussed is EMCN; the disease is cancer.